openPR Logo
Press release

Vaccinium myrtillus Market 2018 to 2028 | Key Players - Eevia Health Oy, ETchem, Sanyuan Jinrui Natural Ingredients Co., Ltd, BioMax Life Sciences, NOW Foods, Bio-Botanica

04-09-2019 02:28 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Vaccinium myrtillus Market 2018 to 2028 | Key Players - Eevia

Vaccinium myrtillus Market: Insights

Vaccinium myrtillus, commonly known as wimberry, bilberry, European blueberry or whortleberry, is a species of shrubs with blue color edible fruit of high medicinal values. Vaccinium myrtillus is distinctly known as common bilberry or blue whortleberry in order to distinguish from other Vaccinium species. Vaccinium myrtillus is majorly found in Europe, Greenland, Iceland, northern Asia, U.S. and Canada. However, majority of the Vaccinium myrtillus is produced in Eastern Europe regions. Vaccinium myrtillus are majorly found in the wild on acidic soil conditions. Vaccinium myrtillus find its application in varieties of end-use industry verticals, and hence a positive outlook can be witnessed for Vaccinium myrtillus market in the upcoming years.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2081

Global Vaccinium myrtillus Market Dynamics

Global scenario of increasing disease burden and extensive R&D efforts for the innovation of drugs are the prime factors supporting the explosively growing pharmaceutical industry world. According to the American Diabetes Association, over 30.3 million Americans were diagnosed with diabetes, which was proved to be the leading cause of death in the United States, in 2015. With increasing prevalence of diabetes, demand for Vaccinium myrtillus products is expected to witness a rise in the U.S and other regions around the world. According to a study published in European Review for Medical and Pharmacological Sciences, Vaccinium myrtillus can be used to provide relief for dry eyes. Vaccinium myrtillus can be used to reduce eye discomfort, where Vaccinium myrtillus extracts plays a vital role in improving tear secretion and plasmatic antioxidant potential in patients suffering from dry eye. According to University of Maryland Medical Center, Vaccinium myrtillus are very rich in anthocyanosides which helps in assisting the viability of blood vessels and ensures healthy circulation throughout the body including capillaries in the eyes. More comprehensive research on Vaccinium myrtillus reveals anthocyanosides present in Vaccinium myrtillus accelerates formulation of the pigment called rhodopsin, which helps in the eyes’ ability to see in darkness as well as improves the adaptability of eyes towards changing light intensity. Vaccinium myrtillus also helps delay cataract development. Vaccinium myrtillus contains a significant amount of anthocyanosides, which assists in minimizing blood clot because of its properties to thwart blood platelets from aggregating. Moreover, anthocyanosides are antioxidants and helps in preventing the oxidizing of cholesterol. Improved vision, reduction in hemorrhagic tendencies in the eyes, improved blood vessel structure are some of the factors because of which Vaccinium myrtillus is widely used in the pharmaceutical industry. High medicinal properties of Vaccinium myrtillus and increasing health-related issues will drive the Vaccinium myrtillus in the forecast period. High demand for Vaccinium myrtillus can be seen in the upcoming years but there are few factors which might impede the overall growth of Vaccinium myrtillus market. Some factors includes adulteration Vaccinium myrtillus extract. Vaccinium myrtillus are often adulterated with intensive dark blue color, such as anthocyanidin-containing extracts or red food coloring such as amaranth dye. Such extracts and dye are harmful for human consumptions. Also, rising global geopolitical tensions resulting in trade wars will negatively impact the overall growth of the Vaccinium myrtillus market during the forecast period.

Global Vaccinium myrtillus Market Segmentation

Vaccinium myrtillus can be segmented on the basis of product type, end-use application and nature. On the basis of product type, Vaccinium myrtillus can be further segmented as fruit extract and leaf extract. On the basis of end-use application, Vaccinium myrtillus can be further segmented as food and bakery products, pharmaceutical industry and cosmetic and personal care industry. Vaccinium myrtillus is widely used in jams, fools, juices and pies. On the basis of nature, the market can be further segmented as fresh and frozen. Frozen form to account for comparatively more share than fresh Vaccinium myrtillus.

Ask For Customized Report @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=2081

Global Vaccinium myrtillus Market Regional Outlook and Competition Tracking

High demand for Vaccinium myrtillus can be seen in North America and Europe region. In the U.S., Vaccinium myrtillus was among the top 20 herbal supplements between 2007 and 2012 in the food and pharmaceutical market. Asia Pacific and Latin America to register high CAGR during the forecast period. Some of the leading manufacturers of Vaccinium myrtillus includes Eevia Health Oy, ETchem, Sanyuan Jinrui Natural Ingredients Co., Ltd, BioMax Life Sciences, NOW Foods, Bio-Botanica, and other global and local players.

You can Buy This Report from Here @ https://www.factmr.com/checkout/2081/S

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/

Read Industrial News : http://insiderstribune.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaccinium myrtillus Market 2018 to 2028 | Key Players - Eevia Health Oy, ETchem, Sanyuan Jinrui Natural Ingredients Co., Ltd, BioMax Life Sciences, NOW Foods, Bio-Botanica here

News-ID: 1695608 • Views:

More Releases from Fact.MR

Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C., Hydro Flask Lead - Fact.MR
Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C …
The global insulated drinkware market was valued at US$ 1.39 billion in 2023 and is forecasted to expand at a 6.3% CAGR over the next ten years. Worldwide sales of insulated drinkware are projected to reach US$ 2.57 billion by 2033-end.This robust growth is driven by increasing consumer awareness of sustainability, rising participation in outdoor activities, and the growing demand for reusable, eco-friendly products amid bans on single-use plastics. The market
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB Ltd, ANSYS, Inc, AT&T Inc, AVEVA Group plc, Bentley Systems
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 | Fact.MR Report
09-02-2025 | Health & Medicine
Fact.MR
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 2035
09-02-2025 | Health & Medicine
Fact.MR
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable

All 5 Releases


More Releases for Vaccinium

03-24-2025 | Health & Medicine
Fact.MR
Vaccinium Myrtillus Market is Growing at CAGR of 6.9% to Achieve USD 720.7 Milli …
The global Vaccinium myrtillus market value is estimated at US$ 369.3 million in 2024. With a projected CAGR of 6.9%, the market is expected to reach US$ 720.7 million by 2034. Growing health awareness, an increase in the prevalence of chronic diseases such as diabetes and cardiovascular disease, and growing demand for natural and functional food ingredients are fueling market growth. The anti-inflammatory and antioxidant properties of the extract have made
Vaccinium Myrtillus Leaf Extract Market Size, Share and Forecast By Key Players- …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Vaccinium Myrtillus Leaf Extract market is anticipated to grow at a compound annual growth rate (CAGR) of 8.5% between 2024 and 2031. The market is expected to grow to USD 8.1 Billion by 2024. The valuation is expected to reach USD 14.33 Billion by 2031. The Vaccinium Myrtillus leaf extract market is experiencing robust growth, fueled by increasing
Vaccinium Macrocarpon Fruit Extract Market Size, Share and Forecast By Key Playe …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Vaccinium Macrocarpon Fruit Extract market is anticipated to grow at a compound annual growth rate (CAGR) of 9.22% between 2024 and 2031. The market is expected to grow to USD 5.68 Billion by 2024. The valuation is expected to reach USD 10.54 Billion by 2031. The Vaccinium Macrocarpon fruit extract market is experiencing significant growth, driven by increasing consumer awareness of its
07-30-2021 | Health & Medicine
Fact.MR
Market Sales Of Vaccinium Myrtillus Is Following Upward Trend And Will See Enorm …
250 page market research report by Fact.MR, ( leading business and competitive intelligence provider), analyzing how Vaccinium myrtillus Market sales will grow During 2018 to 2028 The recent study by Fact.MR on Demand of Vaccinium myrtillus Market offers a 10-year forecast. The Vaccinium myrtillus Sales study analyzes crucial trends that are currently determining the growth of Vaccinium myrtillus Market. To get in-depth information view the report -https://www.factmr.com/report/2081/vaccinium-myrtillus-market This Vaccinium myrtillus market outlook report
Vaccinium myrtillus Market to Showcase Vigorous Demand during the Period until 2 …
Global Vaccinium myrtillus Market Overview Vaccinium myrtillus, commonly known as wimberry, bilberry, European blueberry or whortleberry, is a species of shrubs with blue color edible fruit of high medicinal values. Vaccinium myrtillus is distinctly known as common bilberry or blue whortleberry in order to distinguish from other Vaccinium species. Vaccinium myrtillus is majorly found in Europe, Greenland, Iceland, northern Asia, U.S. and Canada. However, majority of the Vaccinium myrtillus is produced
Vaccinium myrtillus Market to Experience Significant Growth during the Forecast …
Global Vaccinium myrtillus Market Overview Vaccinium myrtillus, commonly known as wimberry, bilberry, European blueberry or whortleberry, is a species of shrubs with blue color edible fruit of high medicinal values. Vaccinium myrtillus is distinctly known as common bilberry or blue whortleberry in order to distinguish from other Vaccinium species. Vaccinium myrtillus is majorly found in Europe, Greenland, Iceland, northern Asia, U.S. and Canada. However, majority of the Vaccinium myrtillus is produced